Compare GOOGL & JNJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GOOGL | JNJ |
|---|---|---|
| Founded | 1998 | 1886 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0T | 505.3B |
| IPO Year | 2004 | 1944 |
| Metric | GOOGL | JNJ |
|---|---|---|
| Price | $327.89 | $220.41 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 44 | 17 |
| Target Price | ★ $325.42 | $220.41 |
| AVG Volume (30 Days) | ★ 27.5M | 8.0M |
| Earning Date | 02-04-2026 | 01-21-2026 |
| Dividend Yield | 0.26% | ★ 2.36% |
| EPS Growth | 34.51 | ★ 71.26 |
| EPS | 10.14 | ★ 11.03 |
| Revenue | ★ $385,476,000,000.00 | $94,193,000,000.00 |
| Revenue This Year | $17.36 | $6.63 |
| Revenue Next Year | $13.56 | $5.49 |
| P/E Ratio | $32.36 | ★ $19.96 |
| Revenue Growth | ★ 13.42 | 5.08 |
| 52 Week Low | $140.53 | $141.50 |
| 52 Week High | $340.49 | $222.17 |
| Indicator | GOOGL | JNJ |
|---|---|---|
| Relative Strength Index (RSI) | 57.77 | 70.85 |
| Support Level | $319.35 | $210.50 |
| Resistance Level | $335.15 | $222.17 |
| Average True Range (ATR) | 7.73 | 4.26 |
| MACD | -0.47 | 0.87 |
| Stochastic Oscillator | 56.36 | 92.24 |
Alphabet is a holding company that wholly owns internet giant Google. The California-based company derives slightly less than 90% of its revenue from Google services, the vast majority of which is advertising sales. Alongside online ads, Google services houses sales stemming from Google's subscription services (YouTube TV and YouTube Music, among others), platforms (sales and in-app purchases on Play Store), and devices (Chromebooks, Pixel smartphones, and smart home products such as Chromecast). Google's cloud computing platform accounts for roughly 10% of Alphabet's revenue. The firm's investments in up-and-coming technologies such as self-driving cars (Waymo), health (Verily), and internet access (Google Fiber) make up the rest.
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.